Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.

G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Abstract Text:

    silvia g bompadreSilvia G Bompadre,yoshiro sohmaYoshiro Sohma,min liMin Li,tzyh-chang hwangTzyh-Chang Hwang,

    Mutations in the gene encoding cystic fibrosis transmembrane conductance regulator (CFTR) result in cystic fibrosis (CF). CFTR is a chloride channel that is regulated by phosphorylation and gated by ATP binding and hydrolysis at its nucleotide binding domains (NBDs). G551D-CFTR, the third most common CF-associated mutation, has been characterized as having a lower open probability (Po) than wild-type (WT) channels. Patients carrying the G551D mutation present a severe clinical phenotype. On the other hand, G1349D, also a mutant with gating dysfunction, is associated with a milder clinical phenotype. Residues G551 and G1349 are located at equivalent positions in the highly conserved signature sequence of each NBD. The physiological importance of these residues lies in the fact that the signature sequence of one NBD and the Walker A and B motifs from the other NBD form the ATP-binding pocket (ABP1 and ABP2, named after the location of the Walker A motif) once the two NBDs dimerize. Our studies show distinct gating characteristics for these mutants. The G551D mutation completely eliminates the ability of ATP to increase the channel activity, and the observed activity is approximately 100-fold smaller than WT-CFTR. G551D-CFTR does not respond to ADP, AMP-PNP, or changes in [Mg(2+)]. The low activity of G551D-CFTR likely represents the rare ATP-independent gating events seen with WT channels long after the removal of ATP. G1349D-CFTR maintains ATP dependence, albeit with a Po approximately 10-fold lower than WT. Interestingly, compared to WT results, the ATP dose-response relationship of G1349D-CFTR is less steep and shows a higher apparent affinity for ATP. G1349D data could be well described by a gating model that predicts that binding of ATP at ABP1 hinders channel opening. Thus, our data provide a quantitative explanation at the single-channel level for different phenotypes presented by patients carrying these two mutations. In addition, these results support the idea that CFTR's two ABPs play distinct functional roles in gating.

    G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Publishing Authors By Initials

    sg bompadreSG Bompadre,y sohmaY Sohma,m liM Li,tc hwangTC Hwang,

    For similar investigative techniques: genetic techniques: gene transfer techniques: transfection research abstracts see: investigative techniques: genetic techniques: gene transfer techniques: transfection research

    PUBMED ID PMID:

    MEDLINE DATE:

    G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of general physiology

    VOLUME: 129

    Page Numbers: 285-98

    Journal Abbreviation: J. Gen. Physiol.

    ISSN: 0022-1295

    DAY: 12

    MONTH: 03

    YEAR: 2007

    G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2985110

    G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Keywords Mesh Terms:

    KEYWORDS: Transfection

    MESH TERMS: physiology

    Chemical & Substance for Abstract: G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. Information

    Substance Name: Adenosine Monophosphate

    Registry Number: 61-19-8

    Grant and Affiliation Information for G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.

    AFFILIATION: Department of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO 65211, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: R01HL53455

    ACRONYM: HL

    MEDLINETA: J Gen Physiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News